Lyox
Intelligence Without Boundaries
Research Library
Crime & SecurityUnited Nations Office on Drugs and Crime2026 EDITION

World Drug Report 2026

The definitive annual analysis of global drug supply, demand, emerging synthetic threats and enforcement outcomes.

EXECUTIVE SUMMARY

Executive Summary

In 2025, an estimated 296 million people worldwide used a drug — a 20% increase over the past decade. Cocaine production reached record highs in Colombia (2,600 t). Fentanyl-driven overdose deaths in North America stabilized at 74,000 following supply-side interdiction. Nitazenes have emerged as a next-generation synthetic opioid threat.

INTRODUCTION

Introduction

This 2026 edition presents a comprehensive assessment of global drug markets, health impacts, and policy responses.

BACKGROUND

Background

Established under the three UN drug conventions (1961, 1971, 1988), UNODC provides the annual authoritative reference for drug statistics.

CURRENT

Current Global Situation

Fentanyl analog seizures declined 12% following US-Mexico-China trilateral supply crackdown. Nitazenes now detected in 24 countries. Global synthetic drug markets growing 8% annually.

REGIONS

Regional Analysis

North America

Fentanyl-driven overdoses stabilizing. Xylazine and nitazenes emerging.

Europe

Record cocaine market EUR 12B/year. Netherlands and Belgium ports central.

Asia-Pacific

Golden Triangle methamphetamine surge. Afghan opium collapse post-2022 Taliban ban.

Middle East

Captagon trafficking from Syria-Iraq corridor persists.

Africa

West Africa emerging transit route for South American cocaine.

Latin America

Colombia cocaine production at record; Mexico cartel fragmentation.

COUNTRIES

Country Analysis

USAMexicoColombiaNetherlandsAfghanistanMyanmarBrazil
KEY FINDINGS

Key Findings

  • 296M users globally, up 20% in 10 years.
  • Cocaine production: record 2,600 t.
  • Nitazenes: emerging next-gen synthetic opioid.
  • AFG opium: down 95% post-Taliban ban.
  • Global fentanyl deaths stabilizing after 2024 peak.
RISKS

Risks

  • Nitazene analogs may exceed fentanyl in lethality.
  • Displacement of Afghan opium to Myanmar and Latin America.
  • Crypto-mediated dark-net markets scaling.
  • Container-port fentanyl precursor flows.
FORECAST

Future Outlook

Synthetic drug dominance to accelerate. Global cocaine consumption to expand across Asia. Precursor chemical governance the critical policy lever.

RECOMMENDATIONS

Recommendations

  • Governments: Precursor scheduling and container-port screening.
  • International bodies: Expand UNODC-WCO Container Control Programme.
  • Businesses: Strengthen banking sector red-flag guidance.
  • Researchers: Nitazene toxicology and treatment protocols.
CASE STUDIES

Case Studies

  • Trilateral fentanyl crackdown (US-MX-CN)
  • Netherlands port scanner deployment
  • Afghan opium ban outcomes
REFERENCES

References

  • 1. UNODC WDR 2026
  • 2. EMCDDA Statistical Bulletin 2026
  • 3. DEA National Drug Threat Assessment 2026
Privacy · Analytics

Lyox uses Google Analytics with IP anonymization to understand how researchers explore the platform. Your data is never sold. You can change this any time in Settings.